Taipei Exchange - Delayed Quote TWD

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)

14.10
+0.15
+(1.08%)
At close: 2:01:26 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
354,173
354,173
315,984
318,237
243,363
Cost of Revenue
110,206
110,206
117,529
125,657
118,571
Gross Profit
243,967
243,967
198,455
192,580
124,792
Operating Expense
199,132
199,132
194,186
184,178
227,586
Operating Income
44,835
44,835
4,269
8,402
-102,794
Net Non Operating Interest Income Expense
-5,976
-5,976
-5,808
-5,639
-7,309
Pretax Income
22,602
22,602
-11,387
3,685
-114,444
Tax Provision
-273
-273
-705
515
4,081
Net Income Common Stockholders
22,875
22,875
-10,682
3,170
-118,525
Diluted NI Available to Com Stockholders
22,875
22,875
-10,682
3,170
-118,525
Basic EPS
0.25
--
-0.12
0.04
-1.32
Diluted EPS
0.25
--
-0.12
0.04
-1.32
Basic Average Shares
91,500
--
89,016.67
90,000
90,000
Diluted Average Shares
91,500
--
89,016.67
90,000
90,000
Total Expenses
309,338
309,338
311,715
309,835
346,157
Net Income from Continuing & Discontinued Operation
22,875
22,875
-10,682
3,170
-118,525
Normalized Income
25,735.80
25,735.80
-8,959.67
3,849.59
-118,449
Interest Income
1,447
1,447
1,490
495
124
Interest Expense
7,423
7,423
7,298
6,134
7,433
Net Interest Income
-5,976
-5,976
-5,808
-5,639
-7,309
EBIT
30,025
30,025
-4,089
9,819
-107,011
EBITDA
50,647
50,647
21,810
38,001
-76,619
Reconciled Cost of Revenue
110,206
110,206
117,529
125,657
118,571
Reconciled Depreciation
20,622
20,622
25,899
28,182
30,392
Net Income from Continuing Operation Net Minority Interest
22,875
22,875
-10,682
3,170
-118,525
Total Unusual Items Excluding Goodwill
-3,576
-3,576
-1,836
-790
-95
Total Unusual Items
-3,576
-3,576
-1,836
-790
-95
Normalized EBITDA
54,223
54,223
23,646
38,791
-76,524
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-715.20
-715.20
-113.67
-110.41
-19
12/31/2021 - 11/27/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4194.TWO Holy Stone Healthcare Co., Ltd.
7.19
-0.28%
 
4170.TWO VBI
13.00
0.00%
 
7607.TWO DuoGenic StemCells corporation
14.05
+2.18%
 
6814.TWO Lukas Biomedical Inc.
25.10
0.00%
 
4724.TWO Meribank Biotech Co., Ltd
15.15
+0.33%
 
7776.TWO Anya
30.00
0.00%
 
6926.TWO Shine-On BioMedical Co.,Ltd.
63.30
-1.09%
 
6610.TWO TWi Biotechnology, Inc.
11.05
+0.45%
 
6652.TWO Eusol Biotech Co.,Ltd.
6.11
-1.77%
 
6848.TWO RBC Bioscience Corporation
18.20
0.00%